Pàgina d'iniciNHIQ • OTCMKTS
add
NantHealth Inc
Tancament anterior
0,00010 $
Interval de preus d'avui
0,00010 $ - 0,00010 $
Capitalit. borsària
2,75 k USD
Volum mitjà
187,00
Ràtio PER
-
Rendibilitat per dividend
-
Borsa principal
OTCMKTS
Notícies dels mercats
Finances
Balanç de resultats
Ingressos
Ingressos nets
(USD) | set. del 2023info | Variació interanual |
---|---|---|
Ingressos | 12,47 M | — |
Despesa d'explotació | 12,17 M | — |
Ingressos nets | -14,99 M | — |
Marge de benefici net | -120,20 | — |
Benefici per acció | — | — |
Ebitda | -175,00 k | — |
Taxa impositiva efectiva | -0,36 % | — |
Balanç
Actiu total
Passiu total
(USD) | set. del 2023info | Variació interanual |
---|---|---|
Efectiu i invers. a curt terme | 5,82 M | — |
Actiu total | 146,48 M | — |
Passiu total | 396,66 M | — |
Capital total | -250,18 M | — |
Accions en circulació | 27,47 M | — |
Ràtio cotització-valor | -0,00 | — |
Rendiment | -8,24 % | — |
Rendibilitat d'inversió | -41,68 % | — |
Flux de caixa
Variació neta de l'efectiu
(USD) | set. del 2023info | Variació interanual |
---|---|---|
Ingressos nets | -14,99 M | — |
Efectiu d'operacions | -7,65 M | — |
Efectiu d'inversió | 11,00 k | — |
Efectiu de finançament | 7,50 M | — |
Variació neta de l'efectiu | -298,00 k | — |
Flux de caixa lliure | -3,94 M | — |
Informació
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Conseller delegat, CO
Data de fundació
7 de jul. 2010
Lloc web
Empleats
373